Delivery Order SPE2DB20D3111-SPE2DB24FA7SM
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $14,222.42 Firm Fixed Price Delivery Order is for the supply of Spiriva HandiHaler 18 mcg capsules. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,291.14 firm fixed-price delivery order is for the supply of 4,564,351,286 units of the pharmaceutical product SPIRIVA HANDIHALER 18 MCG CAP 90S. The contract has an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corporation, a subsidiary of one of the world's largest pharmaceutical distributors, holds a significant Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $15,727.95 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Spiriva Handihaler 18 mcg capsules, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of November 14, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,571.33, is for the delivery of Spiriva HandiHaler 18 mcg capsules over a two-year period, with a completion date of December 3, 2024. The contract is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Spiriva Handihaler 18 mcg capsules. The $44,410.03 firm-fixed-price contract has a completion date of January 5, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, to provide a comprehensive range of medical commodities...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,104.62 Firm Fixed Price delivery order is for the supply of 4,565,857,100 units of the medication Spiriva Handihaler 18 MCG CAP 90S. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a...
- This federal contract award, with ID SPE2DB20D1004|SPE2DB23FE7W4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,738.35 firm fixed-price delivery order is for the supply of 4,558,865,733 units of Spiriva Handihaler 18 mcg medication capsules. The contract has an ultimate completion date of October 25, 2022 and was awarded on October 24, 2022. This delivery order appears to be part of...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,529.09, is for the supply of Spiriva Handihaler 18 mcg capsules. The contract has an ultimate completion date of January 28, 2025 and is a Firm Fixed Price contract type. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $4,473.45, is for the delivery of Spiriva Handihaler 18 mcg capsules. This is a firm-fixed-price delivery order with a completion date of May 19, 2023. The contract is not designated with a set-aside requirement, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,620.04 Firm Fixed Price Delivery Order is for the supply of SPIRIVA HANDIHALER 18 MCG CAP 30S, a respiratory medication, with a period of performance through January 16, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB24FA7SMDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,526.08 Firm Fixed Price delivery order is for the supply of 4,564,641,625 units of Spiriva Handihaler 18 mcg capsules in 90-count packages. The contract has an ultimate completion date of May 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025. This serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was made on a full and open competition basis without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/17/24 |